New push for Hepatitis C cure
Print Edition
China has increased its pace of development for treatment of Hepatitis C with support from the World Health Organization, aiming to eliminate viral hepatitis by 2030.
Zhuang Hui of the Chinese Academy of Engineering, who is honorary director of the Chinese Society of Hepatology, said that effective anti-virals will enable more patients to be cured. China has nearly 10 million Hepatitis C patients. In 2017, about 240,000 new patients were diagnosed.
Zhuang said China’s standard treatment for Hepatitis C — peginterferon — is ineffective and has side effects, low tolerance and a long treatment cycle, leading to a low rate of treatment for Hepatitis C patients.
In 2017, several new Hepatitis C treatments were approved by health authority. Hepatitis C is an infectious disease caused by Hepatitis C virus that primarily affects the liver. Over many years, it often leads to liver disease and occasionally cirrhosis.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
